Clariness, founded in 2005 and headquartered in Germany, is a prominent player in the Health Care and Pharmaceutical industries. The company specializes in comprehensive services for clinical trials, encompassing patient recruitment, retention, surveys, and study feasibility. Through its innovative ClinLife® technology platform, Clariness streamlines the enrollment process and expedites clinical trial start-up timelines for sponsors.
Renowned for its global reach, Clariness operates in over 50 countries and engages more than 15 million patients worldwide in its ClinLife® community. The company's reputation is built on its expertise in digital and social outreach, alongside cost-effective strategies and dependable service delivery. Despite its extensive operations, Clariness has not disclosed recent investment activity. Its established network and innovative approach make it a compelling candidate for investors seeking opportunities in the evolving clinical trial landscape.